| 1 |
35565309 | Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients. | 2022 Apr 27 |
1 |
| 2 |
35574028 | Value of Immunohistochemical Expression of Apelin, Succinate Dehydrogenase B, Chromogranin B, Human Epidermal Growth Factor Receptor-2, Contactin 4, and Succinyl-CoA Synthetase Subunit Beta in Differentiating Metastatic From Non-Metastatic Pheochromocytoma and Paraganglioma. | 2022 |
1 |
| 3 |
35574415 | Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population. | 2022 |
1 |
| 4 |
33280268 | Rapid HER2 cytologic fluorescence in situ hybridization for breast cancer using noncontact alternating current electric field mixing. | 2021 Jan |
2 |
| 5 |
33893247 | Genetic landscape of breast cancer and mutation tracking with circulating tumor DNA in Chinese women. | 2021 Apr 23 |
1 |
| 6 |
34136904 | Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues. | 2021 Jul 6 |
1 |
| 7 |
34266469 | Transcriptome and genome evolution during HER2-amplified breast neoplasia. | 2021 Jul 15 |
1 |
| 8 |
34289525 | Quantitative assessment of HER2 gene amplification of breast cancer using droplet digital PCR. | 2021 Aug |
1 |
| 9 |
31205070 | Storage Conditions and Immunoreactivity of Breast Cancer Subtyping Markers in Tissue Microarray Sections. | 2020 Apr |
1 |
| 10 |
32110671 | Complete response to trastuzumab and chemotherapy in recurrent urothelial bladder carcinoma with HER2 gene amplification: A case report. | 2020 Feb 6 |
1 |
| 11 |
32621174 | Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers. | 2020 Oct |
1 |
| 12 |
32674482 | ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer. | 2020 Jul 14 |
1 |
| 13 |
33010699 | Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer. | 2020 Nov |
1 |
| 14 |
30838039 | Quantitative Analysis of HER2 Amplification by Droplet Digital PCR in the Follow-Up of Gastric Cancer Patients Being Treated with Trastuzumab after Surgery. | 2019 |
1 |
| 15 |
30882204 | Isotopologue Multipoint Calibration for Proteomics Biomarker Quantification in Clinical Practice. | 2019 Apr 16 |
1 |
| 16 |
31197538 | Amplified fluorescence imaging of HER2 dimerization on cancer cells by using a co-localization triggered DNA nanoassembly. | 2019 Jun 13 |
1 |
| 17 |
31455202 | Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue. | 2019 Aug 28 |
2 |
| 18 |
31638234 | Development of recurrence risk score using 95‑gene classifier and its application to formalin‑fixed paraffin‑embedded tissues in ER‑positive, HER2‑negative and node‑negative breast cancer. | 2019 Dec |
1 |
| 19 |
29206917 | Tunicamycin-induced ER stress in breast cancer cells neither expresses GRP78 on the surface nor secretes it into the media. | 2018 Feb 1 |
1 |
| 20 |
29545609 | Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots. | 2018 Mar 15 |
1 |
| 21 |
29866615 | Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal Cancer. | 2018 Sep |
1 |
| 22 |
30087576 | Single-day HER2neu amplification assessment using chip-based digital PCR in formalin-fixed paraffin-embedded breast carcinoma tissue. | 2018 |
2 |
| 23 |
30563489 | A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation study. | 2018 Dec 18 |
1 |
| 24 |
27544315 | Clinical Usefulness of a One-Tube Nested Reverse Transcription Quantitative Polymerase Chain Reaction Assay for Evaluating Human Epidermal Growth Factor Receptor 2 mRNA Overexpression in Formalin-Fixed and Paraffin-Embedded Breast Cancer Tissue Samples. | 2017 |
1 |
| 25 |
27837339 | HER2 mRNA transcript quantitation in breast cancer. | 2017 May |
1 |
| 26 |
28039034 | Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer. | 2017 Mar 20 |
1 |
| 27 |
28039535 | Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients. | 2017 Feb |
1 |
| 28 |
28901323 | Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalin-fixed paraffin-embedded breast and gastric cancer samples. | 2017 |
1 |
| 29 |
26422389 | High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy. | 2016 Jan |
1 |
| 30 |
26626802 | Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples. | 2016 Apr |
1 |
| 31 |
26820945 | Evaluation of Human Epidermal Growth Factor Receptor 2 (HER2) Gene Status in Human Breast Cancer Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Specimens by Fluorescence In Situ Hybridization (FISH). | 2016 |
2 |
| 32 |
27053957 | C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome. | 2016 |
1 |
| 33 |
27065677 | HER2 Expression in Gastric Adenocarcinoma-a Study in a Tertiary Care Centre in South India. | 2016 Mar |
1 |
| 34 |
27618787 | HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status. | 2016 Aug 9 |
1 |
| 35 |
27929428 | HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin. | 2016 Dec 6 |
1 |
| 36 |
25863425 | Clinical significance of assessing Her2/neu expression in gastric cancer with dual tumor tissue paraffin blocks. | 2015 Jun |
9 |
| 37 |
26022247 | Allelic imbalance at the HER2/TOP2A locus in breast cancer. | 2015 May 29 |
1 |
| 38 |
26149442 | Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues. | 2015 Oct |
5 |
| 39 |
23702645 | HER2 gene amplification and protein expression in pancreatic ductal adenocarcinomas. | 2014 |
1 |
| 40 |
24491355 | Intratumoral heterogeneous amplification of ERBB2 and subclonal genetic diversity in gastric cancers revealed by multiple ligation-dependent probe amplification and fluorescence in situ hybridization. | 2014 Apr |
1 |
| 41 |
24529991 | Development of bispecific molecules for the in situ detection of protein-protein interactions and protein phosphorylation. | 2014 Mar 20 |
1 |
| 42 |
25218890 | Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer. | 2014 Oct |
1 |
| 43 |
25236569 | Evaluation of a quantitative RT-PCR assay to detect HER2 mRNA overexpression for diagnosis and selection of trastuzumab therapy in breast cancer tissue samples. | 2014 Dec |
1 |
| 44 |
25279206 | Lack of HER-2 gene amplification and association with pathological and clinical characteristics of differentiated thyroid cancer. | 2014 Nov |
1 |
| 45 |
25400755 | Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues. | 2014 |
2 |
| 46 |
25838812 | HER-2 assessment in formalin-fixed paraffin-embedded breast cancer tissue by well-based reverse phase protein array. | 2014 |
2 |
| 47 |
23036330 | Droplet Digital™ PCR quantitation of HER2 expression in FFPE breast cancer samples. | 2013 Jan |
1 |
| 48 |
23084583 | In situ analysis of HER2 mRNA in gastric carcinoma: comparison with fluorescence in situ hybridization, dual-color silver in situ hybridization, and immunohistochemistry. | 2013 Apr |
1 |
| 49 |
23344868 | Immunohistochemical expression of ErbB2 in adamantinomatous craniopharyngiomas: a possible target for immunotherapy. | 2013 |
1 |
| 50 |
23358413 | Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissue. | 2013 Jun |
1 |